1
Return

Quantum-Capacitance Biosensing Enables Real-Time Monitoring of Naxitamab for Therapeutic Response Stratification in Neuroblastoma

delete2026-08-01
delete0
delete
OA
AI
A
Andy Bruno
R
Ruslán Álvarez-Diduk *
P
Paula Lara
G
Gabriel Maroli
C
Cristina Larrosa
S
Sandra López-Miralles
J
Jaume Mora
C
Carlos J. Rodríguez-Hernández
A
Arben Merkoçi *
DOI:10.1002/smsc.70349delete
deleteOriginal
deleteShare
deleteSave
View PDF
Abstract

Abstract

En 中文
Neuroblastoma, a leading cause of cancer-related mortality in early childhood, relies on anti-GD2 immunotherapy, whose efficacy is critically dependent on systemic drug exposure that remains largely unmonitored in real time, limiting treatment optimization and early response assessment. Here, a first-in-class, label-free electrochemical biosensing platform is reported for the direct quantification of naxitamab in patient-derived samples. The system is based on a laser-assisted reduced graphene oxide–gold nanoparticle (rGO@AuNPs) nanocomposite, enabling ultrasensitive detection through quantum capacitance modulation arising from perturbations in the electronic density of states of graphene upon biomolecular recognition. Laser-assisted fabrication yields nanostructured electrodes with enhanced surface area and conductivity, promoting stable antibody immobilization and reproducible signal transduction. The platform operates in the femtomolar regime, with a linear response between 25 and 300 fM, high specificity against relevant interferents, and robust performance in diluted human serum. A single-point calibration strategy enables accurate quantification while compensating for device variability. Application to retrospective clinical samples reveals distinct post-infusion concentration profiles, enabling early discrimination between responder groups and detection of antidrug antibody development. This work establishes quantum-capacitance biosensing as a generalizable strategy for real-time monitoring of therapeutic antibodies in precision oncology.
Keywords:
label-free quantum-capacitance biosensor
laser-assisted
naxitamab
neuroblastoma
rGO-based composite
single-point calibration
therapeutic drug monitoring
AI Summary

AI Summary

Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.

Journal

S
Small Science
IF:
8.3
Papers:
1.0K
Citations:
3.2K

Organization

U
universitat autónoma de barcelona
Scholars:
312
Papers: 131
Citations: 0
I
Institut de Recerca Sant Joan de Déu
Scholars:
93
Papers: 43
Citations: 825
C
Catalan Institute of Nanoscience and Nanotechnology
Scholars:
52
Papers: 25
Citations: 4
H
hospital sant joan de déu
Scholars:
262
Papers: 104
Citations: 0
Cited Papers

Cited Papers

Citing Papers

Citing Papers